Form 4: Hims & Hers Health, Inc.: Chief Commercial Officer Acquires Restricted Stock Units

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., acquired 169,587 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Summary

• On March 3, 2025, Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc., was granted 169,587 Restricted Stock Units (RSUs).
• These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
• The RSUs are subject to a four-year service-based vesting schedule, with substantially equal quarterly installments vesting on March 15, June 15, September 15, and December 15, starting June 15, 2025.
• Following the transaction, Michael Chi directly owns 169,587 derivative securities.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting a transaction. The grant of RSUs is generally a positive sign as it aligns management's interests with shareholders, but it's a routine event.

Positives

• The grant of RSUs to the Chief Commercial Officer aligns his interests with those of the shareholders, incentivizing him to contribute to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or strategic direction, focusing instead on the details of the stock unit grant.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency regarding the equity holdings of company insiders.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the Chief Commercial Officer to drive company growth.
• Employees may see the RSU grant as a sign of the company's commitment to its leadership team.

Key Dates